Výsledky vyhľadávania - "Won, Elizabeth"

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial Autor Janjigian, Yelena Y, Maron, Steven B, Chatila, Walid K, Millang, Brittanie, Chavan, Shweta S, Alterman, Carly, Chou, Joanne F, Segal, Michal F, Simmons, Marc Z, Momtaz, Parisa, Shcherba, Marina, Ku, Geoffrey Y, Zervoudakis, Alice, Won, Elizabeth S, Kelsen, David P, Ilson, David H, Nagy, Rebecca J, Lanman, Richard B, Ptashkin, Ryan N, Donoghue, Mark T A, Capanu, Marinela, Taylor, Barry S, Solit, David B, Schultz, Nikolaus, Hechtman, Jaclyn F

“…Addition of trastuzumab to first-line chemotherapy improves overall survival in patients with HER2-positive metastatic gastric cancer. We assessed the safety…”
Získať plný text

Issues in the Management of Esophagogastric Cancer in Geriatric Patients Autor Won, Elizabeth

“…Esophagogastric cancers predominantly affect older adults; however, older patients are less likely to be recommended for both curative and palliative…”
Zistit podrobnosti o prístupe

Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer Autor Ku, Geoffrey Y, Kemel, Yelena, Maron, Steve B, Chou, Joanne F, Ravichandran, Vignesh, Shameer, Zarina, Maio, Anna, Won, Elizabeth S, Kelsen, David P, Ilson, David H, Capanu, Marinela, Strong, Vivian E, Molena, Daniela, Sihag, Smita, Jones, David R, Coit, Daniel G, Tuvy, Yaelle, Cowie, Kendall, Solit, David B, Schultz, Nikolaus, Hechtman, Jaclyn F, Offit, Kenneth, Joseph, Vijai, Mandelker, Diana, Janjigian, Yelena Y, Stadler, Zsofia K

“…IMPORTANCE: Among patients with esophagogastric cancers, only individuals who present with known features of heritable cancer syndromes are referred for…”
Získať plný text

Issues in the management of esophageal cancer and geriatric patients Autor Won, Elizabeth

“…Esophageal cancer is a disease occurring in older adults and given the aging population, the incidence of cancer in the elderly will continue to rise. However,…”
Zistit podrobnosti o prístupe

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer Autor Rojas, Luis A., Sethna, Zachary, Soares, Kevin C., Olcese, Cristina, Pang, Nan, Patterson, Erin, Lihm, Jayon, Ceglia, Nicholas, Guasp, Pablo, Chu, Alexander, Yu, Rebecca, Chandra, Adrienne Kaya, Waters, Theresa, Ruan, Jennifer, Amisaki, Masataka, Zebboudj, Abderezak, Odgerel, Zagaa, Payne, George, Derhovanessian, Evelyna, Müller, Felicitas, Rhee, Ina, Yadav, Mahesh, Dobrin, Anton, Sadelain, Michel, Łuksza, Marta, Cohen, Noah, Tang, Laura, Basturk, Olca, Gönen, Mithat, Katz, Seth, Do, Richard Kinh, Epstein, Andrew S., Momtaz, Parisa, Park, Wungki, Sugarman, Ryan, Varghese, Anna M., Won, Elizabeth, Desai, Avni, Wei, Alice C., D’Angelica, Michael I., Kingham, T. Peter, Mellman, Ira, Merghoub, Taha, Wolchok, Jedd D., Sahin, Ugur, Türeci, Özlem, Greenbaum, Benjamin D., Jarnagin, William R., Drebin, Jeffrey, O’Reilly, Eileen M., Balachandran, Vinod P.

“…Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients 1 , yet harbours mutation-derived T cell neoantigens that are suitable for vaccines 2 , 3…”
Získať plný text

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer Autor Sethna, Zachary, Guasp, Pablo, Reiche, Charlotte, Milighetti, Martina, Ceglia, Nicholas, Patterson, Erin, Lihm, Jayon, Payne, George, Lyudovyk, Olga, Rojas, Luis A., Pang, Nan, Ohmoto, Akihiro, Amisaki, Masataka, Zebboudj, Abderezak, Odgerel, Zagaa, Bruno, Emmanuel M., Zhang, Siqi Linsey, Cheng, Charlotte, Elhanati, Yuval, Derhovanessian, Evelyna, Manning, Luisa, Müller, Felicitas, Rhee, Ina, Yadav, Mahesh, Merghoub, Taha, Wolchok, Jedd D., Basturk, Olca, Gönen, Mithat, Epstein, Andrew S., Momtaz, Parisa, Park, Wungki, Sugarman, Ryan, Varghese, Anna M., Won, Elizabeth, Desai, Avni, Wei, Alice C., D’Angelica, Michael I., Kingham, T. Peter, Soares, Kevin C., Jarnagin, William R., Drebin, Jeffrey, O’Reilly, Eileen M., Mellman, Ira, Sahin, Ugur, Türeci, Özlem, Greenbaum, Benjamin D., Balachandran, Vinod P.

“…A fundamental challenge for cancer vaccines is to generate long-lived functional T cells that are specific for tumour antigens. Here we find that mRNA–lipoplex…”
Získať plný text

Management of Localized Esophageal Cancer in the Older Patient Autor Won, Elizabeth, Ilson, David H.

“…Most patients with gastroesophageal cancers are older than 65 years of age. The management of older patients poses challenges because they have multiple…”
Získať plný text

Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer Autor Lumish, Melissa A, Walch, Henry, Maron, Steven B, Chatila, Walid, Kemel, Yelena, Maio, Anna, Ku, Geoffrey Y, Ilson, David H, Won, Elizabeth, Li, Jia, Joshi, Smita S, Gu, Ping, Schattner, Mark A, Laszkowska, Monika, Gerdes, Hans, Jones, David R, Sihag, Smita, Coit, Daniel G, Tang, Laura H, Strong, Vivian E, Molena, Daniela, Stadler, Zsofia K, Schultz, Nikolaus, Janjigian, Yelena Y, Cercek, Andrea

“…The rate of esophagogastric cancer is rising among individuals under 50 years of age. It remains unknown whether early-onset esophagogastric cancer represents…”
Zistit podrobnosti o prístupe

Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer Autor Won, Elizabeth, Basunia, Azfar, Chatila, Walid K, Hechtman, Jaclyn F, Chou, Joanne F, Ku, Geoffrey Y, Chalasani, Sree B, Boyar, Michelle S, Goldberg, Zoe, Desai, Avni M, Tuvy, Yaelle, Berger, Michael F, Tang, Laura, Kelsen, David P, Schattner, Mark, Ilson, David H, Capanu, Marinela, Solit, David B, Schultz, Nikolaus, Janjigian, Yelena Y

“…VEGFR2-directed therapy is commonly used to treat metastatic esophagogastric cancer, but disease progresses in most patients within months. Therapeutic…”
Zistit podrobnosti o prístupe

Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma Autor Moy, Ryan H., Greally, Megan, Chou, Joanne F., Li, Jia, Desai, Avni M., Chalasani, Sree B., Won, Elizabeth, Kelsen, David P., Ilson, David H., Janjigian, Yelena Y., Capanu, Marinela, Ku, Geoffrey Y.

“…Purpose Paclitaxel plus ramucirumab is a standard second-line regimen for patients with advanced gastric adenocarcinoma, but clinical benefit remains modest…”
Získať plný text

First-line pembrolizumab and trastuzumab in HER2-positive esophagogastric cancer Autor Janjigian, Yelena Y., Maron, Steven B., Chatila, Walid K., Millang, Brittanie, Chavan, Shweta S., Alterman, Carly, Chou, Joanne F., Simmons, Marc, Momtaz, Parisa, Shcherba, Marina, Ku, Geoffrey Y., Zervoudakis, Alice, Won, Elizabeth S., Kelsen, David P., Ilson, David H., Nagy, Rebecca J., Lanman, Richard B., Ptashkin, Ryan N., Donoghue, Mark T.A., Capanu, Marinela, Taylor, Barry S., Solit, David B., Schultz, Nikolaus, Hechtman, Jaclyn F.

Získať plný text

Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting Autor Kilari, Deepak, Soto-Perez-de-Celis, Enrique, Mohile, Supriya Gupta, Alibhai, Shabbir M.H., Presley, Carolyn J., Wildes, Tanya M., Klepin, Heidi D., Demark-Wahnefried, Wendy, Jatoi, Amina, Harrison, Robert, Won, Elizabeth, Mustian, Karen M.

“…Cancer and its treatment can lead to a myriad of adverse events and negatively impact quality of life of older cancer patients and survivors. Unmet physical…”
Získať plný text

HER2 Directed Therapy for Gastric/Esophageal Cancers Autor Won, Elizabeth, Janjigian, Yelena J., Ilson, David H.

“…Opinion Statement The majority of patients with esophagogastric cancer present with advanced disease, which is incurable. Systemic chemotherapy can lead to a…”
Získať plný text

Gaps in nutritional research among older adults with cancer Autor Presley, Carolyn J., Dotan, Efrat, Soto-Perez-de-Celis, Enrique, Jatoi, Aminah, Mohile, Supriya G., Won, Elizabeth, Alibhai, Shabbir, Kilari, Deepak, Harrison, Robert, Klepin, Heidi D., Wildes, Tanya M., Mustian, Karen, Demark-Wahnefried, Wendy

“…Nutritional issues among older adults with cancer are an understudied area of research despite significant prognostic implications for treatment side effects,…”
Získať plný text

A nutritional management algorithm in older patients with locally advanced esophageal cancer Autor Moy, Ryan H., Sabwa, Shalom, Maron, Steven B., Shcherba, Marina, Apollo, Arlyn, Janjigian, Yelena Y., Ku, Geoffrey Y., Tew, William P., Wu, Abraham J., Jones, David R., Molena, Daniela, Ilson, David H., Won, Elizabeth

Získať plný text

The use of mole-mapping diagrams to increase skin self-examination accuracy Autor Chiu, Victoria, Won, Elizabeth, Malik, Mohsin, Weinstock, Martin A.

“…Monthly skin self-examination (SSE) is associated with reduced incidence of advanced melanoma, but SSE is prone to error in detecting early changes of…”
Získať plný text

CA125 Level Association With Chemotherapy Toxicity and Functional Status in Older Women With Ovarian Cancer Autor Won, Elizabeth, Hurria, Arti, Feng, Tao, Mohile, Supriya, Owusu, Cynthia, Klepin, Heidi D., Gross, Cary P., Lichtman, Stuart M., Gajra, Ajeet, Tew, William P.

“…ObjectiveOlder women with ovarian cancer have increased cancer-related mortality and chemotherapy toxicity. CA125 is a sensitive biomarker for tumor burden…”
Získať plný text

Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience Autor Won, Elizabeth, Shah, Manish A, Schöder, Heiko, Strong, Vivian E, Coit, Daniel G, Brennan, Murray F, Kelsen, David P, Janjigian, Yelena Y, Tang, Laura H, Capanu, Marinela, Rizk, Nabil P, Allen, Peter J, Bains, Manjit S, Ilson, David H

“…Early metabolic response on 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) during neoadjuvant chemotherapy is PET non-responders have poor…”
Zistit podrobnosti o prístupe

Sebaceous Gland Carcinoma as the Initial Clue to Occult Colon Carcinoma (Muir-Torre Syndrome): 890 Autor Won, Elizabeth S., Feller, Joseph, Feller, Edward R.

Získať plný text

Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome Autor Won, Elizabeth, Yu, Kenneth H, Shamseddine, Ali, Saltz, Leonard, Mukherjee, Deborah, Haydar, Ali, El-Olayan, Ashwaq, Temraz, Sally, Naghy, Mohamed, Makanjoula, Dorothy, O'Reilly, Eileen M, Abou-Alfa, Ghassan K

Zistit podrobnosti o prístupe